Acton, Massachusetts
United States
22
2025-12-04
The entities that hold a legal rights for patent applications filed by inventor Schnute Mark Edward:
Mark Edward Schnute from Acton, US has applied for patents for these inventions. The list has both pending applications and granted patents:
Lipid Compounds and Uses Thereof
#2 | 2024-11-07N-substituted-dioxocyclobutenylamino-3-hydroxy-picolinamides useful as CCR6 inhibitors
#3 | 2022-01-06Aminopyrimidinyl derivatives
#4 | 2021-07-08N-substituted-dioxocyclobutenylamino-3-hydroxy-picolinamides useful as CCR6 inhibitors
#5 | 2021-01-07Bruton's Tyrosine Kinase Inhibitors
#6 | 2020-03-26N-substituted-dioxocyclobutenylamino-3-hydroxy-picolinamides useful as CCR6 inhibitors
#7 | 2020-02-06RORC2 INHIBITORS AND METHODS OF USE THEREOF
#8 | 2019-12-26Methyl- and Trifluromethyl-Substituted Pyrrolopyridine Modulators of RORC2 and Methods of Use Thereof
#9 | 2019-07-04Bruton's tyrosine kinase inhibitors
#10 | 2019-05-23Methyl- and trifluromethyl-substituted pyrrolopyridine modulators of RORC2 and methods of use thereof
#11 | 2019-05-16RORC2 INHIBITORS AND METHODS OF USE THEREOF
#12 | 2018-10-04RORC2 INHIBITORS AND METHODS OF USE THEREOF
#13 | 2018-09-27Sulfonamide-substituted indole modulators of RORC2 and methods of use thereof
#14 | 2018-06-21Methyl- and trifluoromethyl-substituted pyrrolopyridine modulators of RORC2 and methods of use therof
#15 | 2018-03-29RORC2 INHIBITORS AND METHODS OF USE THEREOF
#16 | 2018-01-04Methyoxy-substituted pyrrolopyridine modulators of RORC2 and methods of use thereof
#17 | 2017-10-05Bruton's tyrosine kinase inhibitors
#18 | 2017-08-17Methyl- and trifluoromethyl-substituted pyrrolopyridine modulators of RORC2 and methods of use thereof
#19 | 2017-08-17RORC2 INHIBITORS AND METHODS OF USE THEREOF
#20 | 2016-03-31Methyl- and trifluoromethyl-substituted pyrrolopyridine modulators of RORC2 and methods of use thereof
#21 | 2016-02-18RORC2 INHIBITORS AND METHODS OF USE THEREOF
#22 | 2015-10-15Bruton's Tyrosine Kinase Inhibitors
1320852 ⎘